GI & Endoscopy

RedHill Biopharma announced all enrolled patients completed treatment for the phase II study of its irritable bowel syndrome with diarrhea drug.

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 10 to July 14.

The American Cancer Society awarded five community health centers $100,000 in grants to increase colorectal cancer screenings in American Indian and Alaska Native populations.

VMG Health completed a regional analysis of case volume per specialty as a percent of total cases at multispecialty ASCs through its VMG Health's Multi-Specialty ASC Intellimarker 2017.

David Landy, MD, is a gastroenterologist at Birmingham (Ala.) Gastroenterology.

With 28 offices throughout Arizona, Phoenix-based Arizona Digestive Health has been serving the state since 2007.

Researchers working with StemSynergy Therapeutics discovered a class of WNT inhibitors that block colorectal cancer growth with minimal gastrointestinal toxicity.

Here are the five most read gastroenterology/endoscopy stories from July 10 to July 14, 2017.

Philip Nagel, MD, is a gastroenterologist at Crystal Lake, Ill.-based Gastroenterology & Internal Medicine Specialists.

Here are three practices with gastroenterology services making news: